Endogenous lymphokine activated killer cell activity and cytogenetic response in chronic myelogenous leukaemia

A Meseri1, V Delwail, A Brizard

  • 1URA C.N.R.S. 1338, Centre de Recherches sur les Maladies du Sang, Université de Poitiers, France.

Insights

Alpha-interferon (alpha-IFN) therapy may enhance chronic myelogenous leukaemia (CML) remission by boosting natural killer (NK) and lymphokine-activated killer (LAK) cell activity. This suggests an indirect immune surveillance mechanism for alpha-IFN in CML treatment.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Alpha-interferon (alpha-IFN) can induce lymphokine-activated killer (LAK) cytotoxicity independently of interleukin-2 (IL2).
  • The mechanism by which alpha-IFN reduces Philadelphia chromosome-positive (Ph1+) clones in chronic myelogenous leukaemia (CML) is not fully understood.

Purpose of the Study:

  • To investigate if alpha-interferon's efficacy in CML treatment is mediated by the generation of natural killer (NK) or LAK activity.
  • To correlate NK/LAK activity with cytogenetic remission in CML patients undergoing alpha-IFN therapy.

Main Methods:

  • NK and LAK cytotoxicity were assessed using NK-sensitive (K562) and NK-resistant (Raji) cell lines in a colony-growth inhibition assay.
  • Effector cells were patient blood mononuclear cells (MC) without in vitro activation.
  • 16 CML patients treated with alpha-IFN were evaluated.

Main Results:

  • Thirteen of 16 patients achieved complete or partial cytogenetic remission, exhibiting significantly high NK and/or LAK activity compared to normal controls.
  • Two patients who did not achieve remission showed no detectable NK or LAK cells, while one had NK activity within normal limits.
  • No NK or LAK cells were detected in two non-remitting patients.

Conclusions:

  • The findings support the hypothesis that alpha-interferon exerts an indirect effect on CML cells.
  • This indirect effect may be mediated by immune surveillance mechanisms involving NK and LAK cells.
  • Alpha-IFN therapy could enhance CML remission through the induction of anti-leukaemic immune responses.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...